AMGN vs VRTX
AMGN and VRTX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | AMGNAmgen Inc. | VRTXVERTEX PHARMACEUTICALS INC / MA |
|---|---|---|
| Market cap | $201.83B | $134.02B |
| P/E (TTM) | 26.0 | 31.3 |
| P/B | 21.96 | 6.92 |
| Dividend yield | 2.54% | — |
| Revenue | $37.22B(TTM) | $12.22B(TTM) |
| Net income | $7.80B(TTM) | $4.34B(TTM) |
| EPS, diluted | $14.37(TTM) | $16.85(TTM) |
Figures from SEC filings · for reference only · not investment advice
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)